Basic and Translational Science: A Report from the GRAPPA 2016 Annual Meeting

Area of Science:

• Immunology
• Dermatology
• Rheumatology

Background:

• Psoriasis and psoriatic arthritis (PsA) treatments are advancing due to a better grasp of inflammatory processes.
• Innate immunity and specific cytokines, particularly within the IL-23-IL-17 axis, are recognized as crucial in psoriatic disease pathogenesis.

Purpose of the Study:

• To summarize recent scientific discussions regarding the IL-17-related pathways.
• To explore the connection between IL-17 pathways and the development of psoriasis and PsA.

Main Methods:

• Literature review of recent advancements in understanding psoriasis and PsA.
• Analysis of the role of innate immunity and cytokine involvement, specifically the IL-23-IL-17 axis.

Main Results:

• Improved understanding of cell subsets and mediators driving inflammation and tissue damage in psoriasis and PsA.
• Identification of the IL-23-IL-17 axis as a central pathway in psoriatic plaque and joint inflammation.

Conclusions:

• The IL-23-IL-17 axis is a critical mediator in the immunopathogenesis of psoriasis and PsA.
• Advances in understanding these pathways are paving the way for more effective therapeutic strategies.